Kuni Umi AI Securities Review - Is It Good for Beginner Traders? - WikiFX
摘要：Kuni Umi AI Securities is regulated by FSA, offering services in hedge funds, face-to-face financial product transactions, and investment banking.
| Kuni Umi AI Securities Review Summary | |
| Founded | 2007 |
| Registered Country/Region | Japan |
| Regulation | FSA |
| Products & Services | Hedge Fund, Face-to-face transactions of financial products, Investment banking (M&A Advisory) |
| Demo Account | ❌ |
| Trading Platform | / |
| Minimum Deposit | / |
| Customer Support | Phone: +81-3-5288-6766 |
| Fax: +81-3-5288-6767 | |
| Address: 6th Floor Marunouchi-nakadori Bldg. 2-2-3 Marunouchi, Chiyoda-ku, Tokyo, Japan, 100-0005 | |
Founded in 2007, Kuni Umi AI Securities is a Japan-based financial firm regulated by the Financial Services Agency (FSA). They offer a range of services including hedge funds, face-to-face financial product transactions, and investment banking services like M&A advisory. However, there's limited info on trading fees and accounts.
Pros and Cons
| Pros | Cons |
| Regulated by FSA | Limited info on accounts |
| Diverse customer support channels | Limited info on trading fees |
| Various products and services | No demo accounts |
| Lack of info on trading platforms |
Is Kuni Umi AI Securities Legit?
Yes, Kuni Umi AI Securities is currently regulated by FSA with a retail forex license.
| Regulated Country | Regulated Authority | Regulated Entity | Current Status | License Type | License Number |
 | The Financial Services Agency (FSA) | くにうみＡＩ証券株式会社 | Regulated | Retail Forex License | 関東財務局長（金商）第1627号 |
Products and Services
Kuni Umi AI Securities offers diverse product services, including handling world-renowned hedge fund products with access to designated funds and tailor-made portfolios. They also provide face-to-face transactions centered on stocks and futures, offering portfolio building services and exclusive trading services.
Additionally, they offer investment banking services, including M&A advisory, auction deals related to the consolidation of listed subsidiaries, patent portfolio sales, business succession/inheritance, and cross-border deals with Asia such as China and the United States.
